Most frequent bacterial infections in patients with covid-19 inside the intensive care unit
DOI:
https://doi.org/10.35381/s.v.v7i2.2847Keywords:
Coinfection, Respiratory Tract Infections, Bronchitis, (Source: DeCS)Abstract
Objective: to describe the most frequent bacterial infections in patients with COVID-19 within the Intensive Care Unit. Method: We worked with a bibliographic review on specialized topics in medical sciences, nursing and epidemiology at a national and international level. Results and conclusion: Coinfection with other microorganisms, such as bacteria and fungi, is a factor that can increase disease symptoms and mortality. The clinical features of lung lesions due to Covid-19 can be difficult to distinguish from bacterial pneumonia.
Downloads
References
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells. 2021;10(12):3592. Published 2021 Dec 20. doi:10.3390/cells10123592
Tang KT, Hsu BC, Chen DY. Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review. Front Immunol. 2021;12:645013. Published 2021 Mar 12. doi:10.3389/fimmu.2021.645013
Saad MA, Alfishawy M, Nassar M, Mohamed M, Esene IN, Elbendary A. COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases. Curr Rheumatol Rev. 2021;17(2):193-204. doi:10.2174/1573397116666201029155856
Aguilera-Calzadilla Y, Diaz-Morales Y, Ortiz-Díaz L, Gonzalez--Martínez O, Lovelle-Enríquez O, Sánchez-Álvarez M. Infecciones bacterianas asociadas a la COVID-19 en pacientes de una unidad de cuidados intensivos [Bacterial infections associated with COVID-19 in patients of the Intensive Care Unit]. Revista Cubana de Medicina Militar [Internet]. 2020; 49 (3) Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/793
Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622-1629. doi:10.1016/j.cmi.2020.07.016
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266-275. doi:10.1016/j.jinf.2020.05.046
Ripa M, Galli L, Poli A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021;27(3):451-457. doi:10.1016/j.cmi.2020.10.021
Aydogdu ALF. Challenges faced by nurse managers during the COVID-19 pandemic: an integrative review. J Res Nurs. 2023;28(1):54-69. doi:10.1177/17449871221124968
Ozmen S, Arslan Yurumezoglu H. Nurse managers' challenges and opportunities in the COVID-19 pandemic crisis: A qualitative descriptive study. J Nurs Manag. 2022;30(7):2609-2619. doi:10.1111/jonm.13817
Vázquez-Calatayud M, Regaira-Martínez E, Rumeu-Casares C, Paloma-Mora B, Esain A, Oroviogoicoechea C. Experiences of frontline nurse managers during the COVID-19: A qualitative study. J Nurs Manag. 2022;30(1):79-89. doi:10.1111/jonm.13488
Taysi MR, Yildirim F, Simsek M, Dural HI, Sencan I. Secondary Infections in Critical Patients with COVID-19 Associated ARDS in the ICU: Frequency, Microbiologic Characteristics and Risk Factors. J Coll Physicians Surg Pak. 2023;33(2):181-187. doi:10.29271/jcpsp.2023.02.181
Zuccon W, Comassi P, Adriani L, et al. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy. Am J Emerg Med. 2021;45:156-161. doi:10.1016/j.ajem.2020.08.005
White JH. A Phenomenological Study of Nurse Managers' and Assistant Nurse Managers' Experiences during the COVID-19 Pandemic in the United States. J Nurs Manag. 2021;29(6):1525-1534. doi:10.1111/jonm.13304
Dioh W, Chabane M, Tourette C, et al. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):42. Published 2021 Jan 11. doi:10.1186/s13063-020-04998-5
Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):897. Published 2020 Oct 28. doi:10.1186/s13063-020-04819-9
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jessica Alexandra Miguez-Agama, Neris Marina Ortega-Guevara, María Aidé Dávila-Quishpe, Myrian Cecilia Sandoval-Rueda
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
